{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:08Z","timestamp":1707524288053},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.7759\/cureus.16808","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T17:11:03Z","timestamp":1627837863000},"source":"Crossref","is-referenced-by-count":1,"title":["Correlation Between the Gut Microbiome and Immunotherapy Response in Inflammatory Bowel Disease: A Systematic Review of the Literature"],"prefix":"10.7759","author":[{"given":"Katarzyna","family":"Karpinska-Leydier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashvini","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Alshowaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuruddhika","family":"Iroshani Jayarathna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya Bala Anthony Manisha R","family":"Salibindla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokul","family":"Paidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin Ekin","family":"Ergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i12.1465","article-title":"Anti-tumor necrosis factor \u03b1 therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis","volume":"25","author":"Petito V","year":"2019","unstructured":"Petito V, Graziani C, Lopetuso LR, et al.. Anti-tumor necrosis factor \u03b1 therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol. 2019, 25:1465-77. 10.3748\/wjg.v25.i12.1465","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i40.11321","article-title":"Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease","volume":"21","author":"Babickova J","year":"2015","unstructured":"Babickova J, Gardlik R. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol. 2015, 21:11321-30. 10.3748\/wjg.v21.i40.11321","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.06.017","article-title":"IL-33 and the intestine: The good, the bad, and the inflammatory","volume":"100","author":"Hodzic Z","year":"2017","unstructured":"Hodzic Z, Schill EM, Bolock AM, Good M. IL-33 and the intestine: The good, the bad, and the inflammatory. Cytokine. 2017, 100:1-10. 10.1016\/j.cyto.2017.06.017","journal-title":"Cytokine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i18.2204","article-title":"Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease","volume":"25","author":"He C","year":"2019","unstructured":"He C, Wang H, Liao WD, Peng C, Shu X, Zhu X, Zhu ZH. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease. World J Gastroenterol. 2019, 25:2204-16. 10.3748\/wjg.v25.i18.2204","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nature18849","article-title":"Interactions between the microbiota and pathogenic bacteria in the gut","volume":"535","author":"B\u00e4umler AJ","year":"2016","unstructured":"B\u00e4umler AJ, Sperandio V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature. 2016, 535:85-93. 10.1038\/nature18849","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8201672","article-title":"New frontiers in genetics, gut microbiota, and immunity: a Rosetta Stone for the pathogenesis of inflammatory bowel disease","volume":"2017","author":"Zhou M","year":"2017","unstructured":"Zhou M, He J, Shen Y, Zhang C, Wang J, Chen Y. New frontiers in genetics, gut microbiota, and immunity: a Rosetta Stone for the pathogenesis of inflammatory bowel disease. Biomed Res Int. 2017, 2017:8201672. 10.1155\/2017\/8201672","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140301","article-title":"Genome-wide association studies of the human gut microbiota","volume":"10","author":"Davenport ER","year":"2015","unstructured":"Davenport ER, Cusanovich DA, Michelini K, Barreiro LB, Ober C, Gilad Y. Genome-wide association studies of the human gut microbiota. PLoS One. 2015, 10:e0140301. 10.1371\/journal.pone.0140301","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa EA","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al.. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019, 4:293-305. 10.1038\/s41564-018-0306-4","journal-title":"Nat Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170034","article-title":"Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease","volume":"12","author":"Vrakas S","year":"2017","unstructured":"Vrakas S, Mountzouris KC, Michalopoulos G, Karamanolis G, Papatheodoridis G, Tzathas C, Gazouli M. Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLoS One. 2017, 12:e0170034. 10.1371\/journal.pone.0170034","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2019.02.008","article-title":"Chronic inflammatory diseases: are we ready for microbiota-based dietary intervention?","volume":"8","author":"Viennois E","year":"2019","unstructured":"Viennois E, Gewirtz AT, Chassaing B. Chronic inflammatory diseases: are we ready for microbiota-based dietary intervention?. Cell Mol Gastroenterol Hepatol. 2019, 8:61-71. 10.1016\/j.jcmgh.2019.02.008","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000344","article-title":"Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria","volume":"21","author":"Wang W","year":"2015","unstructured":"Wang W, Jovel J, Halloran B, et al.. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis. 2015, 21:1419-27. 10.1097\/MIB.0000000000000344","journal-title":"Inflamm Bowel Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2016.1215805","article-title":"Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome","volume":"7","author":"Zeber-Lubecka N","year":"2016","unstructured":"Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, et al.. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes. 2016, 7:397-413. 10.1080\/19490976.2016.1215805","journal-title":"Gut Microbes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1121364","article-title":"The intersection of TNF, IBD and the microbiome","volume":"7","author":"Jones-Hall YL","year":"2016","unstructured":"Jones-Hall YL, Nakatsu CH. The intersection of TNF, IBD and the microbiome. Gut Microbes. 2016, 7:58-62. 10.1080\/19490976.2015.1121364","journal-title":"Gut Microbes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002034","article-title":"Combination antibiotics improves disease activity and alters microbial communities in children with ulcerative colitis","volume":"67","author":"Kordy K","year":"2018","unstructured":"Kordy K, Romeo AC, Lee DJ, et al.. Combination antibiotics improves disease activity and alters microbial communities in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2018, 67:e60-3. 10.1097\/MPG.0000000000002034","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv223","article-title":"Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis","volume":"10","author":"Alipour M","year":"2016","unstructured":"Alipour M, Zaidi D, Valcheva R, et al.. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J Crohns Colitis. 2016, 10:462-71. 10.1093\/ecco-jcc\/jjv223","journal-title":"J Crohns Colitis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002140","article-title":"Enteric virome and bacterial microbiota in children with ulcerative colitis and Crohn disease","volume":"68","author":"Fernandes MA","year":"2019","unstructured":"Fernandes MA, Verstraete SG, Phan TG, et al.. Enteric virome and bacterial microbiota in children with ulcerative colitis and Crohn disease. J Pediatr Gastroenterol Nutr. 2019, 68:30-6. 10.1097\/MPG.0000000000002140","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.05.023","article-title":"Gut mycobiota in immunity and inflammatory disease","volume":"50","author":"Li XV","year":"2019","unstructured":"Li XV, Leonardi I, Iliev ID. Gut mycobiota in immunity and inflammatory disease. Immunity. 2019, 50:1365-79. 10.1016\/j.immuni.2019.05.023","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/nxz302","article-title":"Gut microbial metabolites and biochemical pathways involved in irritable bowel syndrome: effects of diet and nutrition on the microbiome","volume":"150","author":"James SC","year":"2020","unstructured":"James SC, Fraser K, Young W, McNabb WC, Roy NC. Gut microbial metabolites and biochemical pathways involved in irritable bowel syndrome: effects of diet and nutrition on the microbiome. J Nutr. 2020, 150:1012-21. 10.1093\/jn\/nxz302","journal-title":"J Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1906.06064","article-title":"Role of probiotics in human gut microbiome-associated diseases","volume":"29","author":"Kim SK","year":"2019","unstructured":"Kim SK, Guevarra RB, Kim YT, et al.. Role of probiotics in human gut microbiome-associated diseases. J Microbiol Biotechnol. 2019, 29:1335-40. 10.4014\/jmb.1906.06064","journal-title":"J Microbiol Biotechnol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0083-2","article-title":"Systemic effects of gut microbiota and its relationship with disease and modulation","volume":"16","author":"Ho JT","year":"2015","unstructured":"Ho JT, Chan GC, Li JC. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol. 2015, 16:21. 10.1186\/s12865-015-0083-2","journal-title":"BMC Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02211","article-title":"Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis","volume":"9","author":"Sham HP","year":"2018","unstructured":"Sham HP, Bazett M, Bosiljcic M, et al.. Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis. Front Immunol. 2018, 9:2211. 10.3389\/fimmu.2018.02211","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102283","article-title":"Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy","volume":"9","author":"Schierov\u00e1 D","year":"2020","unstructured":"Schierov\u00e1 D, B\u0159ezina J, Mr\u00e1zek J, Fliegerov\u00e1 KO, Kvasnov\u00e1 S, Bajer L, Drastich P. Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy. Cells. 2020, 9:10.3390\/cells9102283","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13276","article-title":"Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?","volume":"197","author":"Moulton CD","year":"2019","unstructured":"Moulton CD, Pavlidis P, Norton C, Norton S, Pariante C, Hayee B, Powell N. Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?. Clin Exp Immunol. 2019, 197:308-18. 10.1111\/cei.13276","journal-title":"Clin Exp Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024845","article-title":"Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study","volume":"100","author":"Chen DL","year":"2021","unstructured":"Chen DL, Dai YC, Zheng L, Chen YL, Zhang YL, Tang ZP. Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study. Medicine (Baltimore). 2021, 100:e24845. 10.1097\/MD.0000000000024845","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1634-x","article-title":"Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease","volume":"10","author":"Wang SL","year":"2019","unstructured":"Wang SL, Shao BZ, Zhao SB, et al.. Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease. Cell Death Dis. 2019, 10:391. 10.1038\/s41419-019-1634-x","journal-title":"Cell Death Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref27","unstructured":"PubMed. (2021). Accessed. April 29, 2021: https:\/\/pubmed.ncbi.nlm.nih.gov\/."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76175-2","article-title":"Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis","volume":"10","author":"Sakurai T","year":"2020","unstructured":"Sakurai T, Nishiyama H, Sakai K, et al.. Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis. Sci Rep. 2020, 10:19186. 10.1038\/s41598-020-76175-2","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001130","article-title":"Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo","volume":"69","author":"O'Reilly C","year":"2020","unstructured":"O'Reilly C, O'Sullivan \u00d3, Cotter PD, et al.. Encapsulated cyclosporine does not change the composition of the human microbiota when assessed ex vivo and in vivo. J Med Microbiol. 2020, 69:854-63. 10.1099\/jmm.0.001130","journal-title":"J Med Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213108","article-title":"Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome","volume":"14","author":"Li E","year":"2019","unstructured":"Li E, Zhang Y, Tian X, et al.. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome. PLoS One. 2019, 14:e0213108. 10.1371\/journal.pone.0213108","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000065","article-title":"The cut microbiota in collagenous colitis shares characteristics with inflammatory bowel disease-associated dysbiosis","volume":"10","author":"Carstens A","year":"2019","unstructured":"Carstens A, Dicksved J, Nelson R, et al.. The cut microbiota in collagenous colitis shares characteristics with inflammatory bowel disease-associated dysbiosis. Clin Transl Gastroenterol. 2019, 10:e00065. 10.14309\/ctg.0000000000000065","journal-title":"Clin Transl Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.09.009","article-title":"Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course","volume":"24","author":"Schirmer M","year":"2018","unstructured":"Schirmer M, Denson L, Vlamakis H, et al.. Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course. Cell Host Microbe. 2018, 24:600-610.e4. 10.1016\/j.chom.2018.09.009","journal-title":"Cell Host Microbe"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601621","article-title":"Host-microbiota interactions shape local and systemic inflammatory diseases","volume":"198","author":"Grigg JB","year":"2017","unstructured":"Grigg JB, Sonnenberg GF. Host-microbiota interactions shape local and systemic inflammatory diseases. J Immunol. 2017, 198:564-71. 10.4049\/jimmunol.1601621","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i30.5469","article-title":"Treating children with inflammatory bowel disease: Current and new perspectives","volume":"23","author":"Guariso G","year":"2017","unstructured":"Guariso G, Gasparetto M. Treating children with inflammatory bowel disease: Current and new perspectives. World J Gastroenterol. 2017, 23:5469-85. 10.3748\/wjg.v23.i30.5469","journal-title":"World J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/srep19032","article-title":"Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation","volume":"6","author":"Agus A","year":"2016","unstructured":"Agus A, Denizot J, Th\u00e9venot J, et al.. Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci Rep. 2016, 6:19032. 10.1038\/srep19032","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-016-0437-0","article-title":"Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?","volume":"16","author":"Eun CS","year":"2016","unstructured":"Eun CS, Kwak MJ, Han DS, et al.. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?. BMC Gastroenterol. 2016, 16:28. 10.1186\/s12876-016-0437-0","journal-title":"BMC Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease","volume":"18","author":"Lewis JD","year":"2015","unstructured":"Lewis JD, Chen EZ, Baldassano RN, et al.. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015, 18:489-500. 10.1016\/j.chom.2015.09.008","journal-title":"Cell Host Microbe"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61983-correlation-between-the-gut-microbiome-and-immunotherapy-response-in-inflammatory-bowel-disease-a-systematic-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:48Z","timestamp":1707507228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61983-correlation-between-the-gut-microbiome-and-immunotherapy-response-in-inflammatory-bowel-disease-a-systematic-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.16808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}